Literature DB >> 6095282

Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9.

R G DiScipio, M R Gehring, E R Podack, C C Kan, T E Hugli, G H Fey.   

Abstract

The nucleotide sequence coding for the ninth component of human complement (C9) has been determined and the corresponding amino acid sequence has been derived. A human liver cDNA library was screened by the colony-hybridization technique using two radiolabeled oligonucleotide probes that correspond to known regions of the C9 amino acid sequence. Two recombinant plasmids were isolated and their cDNA inserts were sequenced. The derived protein sequence consists of 537 amino acids in a single polypeptide chain. A profile of the hydropathic index versus sequence number indicates that the amino-terminal half of C9 is predominantly hydrophilic in character whereas the carboxyl-terminal section of this protein is more hydrophobic. The amphipathic organization of the primary structure of C9 is consistent with the known potential of polymerized C9 to penetrate lipid bilayers, causing the formation of transmembrane channels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095282      PMCID: PMC392133          DOI: 10.1073/pnas.81.23.7298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase.

Authors:  D N Podell; G N Abraham
Journal:  Biochem Biophys Res Commun       Date:  1978-03-15       Impact factor: 3.575

Review 2.  Molecular biology of cellular membranes with applications to immunology.

Authors:  S J Singer
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

3.  The ninth component of human complement: isolation, description and mode of action.

Authors:  U Hadding; H J Müller-Eberhard
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

Review 4.  The lesions in cell membranes caused by complement.

Authors:  J H Humphrey; R R Dourmashkin
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  The chromatographic determination of cystine and cysteine residues in proteins as s-beta-(4-pyridylethyl)cysteine.

Authors:  M Friedman; L H Krull; J F Cavins
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

6.  Quantitative measurement of C9 sites and their association to the ring-like "lesions" on complementlysed membranes: a morphometric immunoferritin study.

Authors:  E W Rauterberg; B Ungemach; H J Gebest
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

7.  Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases.

Authors:  S Ruddy; L K Everson; P H Schur; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

8.  Fluorescence reaction for amino acids.

Authors:  M Roth
Journal:  Anal Chem       Date:  1971-06       Impact factor: 6.986

9.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03

10.  Molecular analysis of the membrane attack mechanism of complement.

Authors:  W P Kolb; J A Haxby; C M Arroyave; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  36 in total

1.  An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.

Authors:  Ann Orren; Ann M O'Hara; B Paul Morgan; Anthony P Moran; Reinhard Würzner
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  TaqI polymorphism at the human complement component C9 gene.

Authors:  E Coto; O Domínguez; E Martínez-Naves; J M Urra; V Gutiérrez; C López-Larrea
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

3.  Topology of the membrane-bound form of complement protein C9 probed by glycosylation mapping, anti-peptide antibody binding, and disulfide modification.

Authors:  Véronique Rossi; Yunxia Wang; Alfred F Esser
Journal:  Mol Immunol       Date:  2010-02-12       Impact factor: 4.407

4.  Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.

Authors:  J Tschopp; T E Mollnes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits.

Authors:  A Abraha; B P Morgan; J P Luzio
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1.

Authors:  Ryan McCormack; Lesley R de Armas; Motoaki Shiratsuchi; Jahir E Ramos; Eckhard R Podack
Journal:  J Innate Immun       Date:  2012-12-15       Impact factor: 7.349

8.  Genomic organization of human complement protein C8 alpha and further examination of its linkage to C8 beta.

Authors:  G A Michelotti; J V Snider; J M Sodetz
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

9.  In situ hybridization mapping of the growth hormone receptor (GHR) gene assigns a linkage group (C9, FS, GHR, and S0105) to chromosome 16 in pigs.

Authors:  B P Chowdhary; H Ellegren; M Johansson; L Andersson; I Gustavsson
Journal:  Mamm Genome       Date:  1994-03       Impact factor: 2.957

Review 10.  Killing machines: three pore-forming proteins of the immune system.

Authors:  Ryan McCormack; Lesley de Armas; Motoaki Shiratsuchi; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.